Health Care

July 14, 2013 7:32 PM

FDA approves new treatment for a type of late-stage lung cancer

The U.S. Food and Drug Administration has approved use of the drug Gilotrif for patients with a form of late stage non-small cell lung cancer.

Related content



Editor's Choice Videos